Goldman Sachs
OSIR

Goldman Sachs’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Goldman Sachs’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-272,227
Closed -$5.17M – 5548
2019
Q1 		$5.17M Buy
272,227
+260,246
+2,172% +$4.22M ﹤0.01% 2944
2018
Q4 		$162K Buy
+11,981
New +$134K ﹤0.01% 4889
2016
Q4 		– Sell
-33,927
Closed -$168K – 7335
2016
Q3 		$168K Sell
33,927
-16,494
-33% -$84.4K ﹤0.01% 5939
2016
Q2 		$257K Sell
50,421
-4,913
-9% -$26.5K ﹤0.01% 5475
2016
Q1 		$316K Buy
55,334
+8,363
+18% +$58.4K ﹤0.01% 5230
2015
Q4 		$488K Sell
46,971
-3,062
-6% -$41.6K ﹤0.01% 4944
2015
Q3 		$924K Buy
+50,033
New +$966K ﹤0.01% 4560
2014
Q4 		– Sell
-13,276
Closed -$167K – 7631
2014
Q3 		$167K Buy
+13,276
New +$189K ﹤0.01% 6305
2014
Q1 		– Sell
-13,975
Closed -$225K – 7151
2013
Q4 		$225K Buy
13,975
+1,200
+9% +$19.1K ﹤0.01% 5890
2013
Q3 		$213K Buy
+12,775
New +$189K ﹤0.01% 5830

Other funds holding OSIR

FGAM
Financial Gravity Asset Management Lakeway, Texas $562M AUM

Goldman Sachs's OSIR Position: Q2 2019 in Review

Goldman Sachs sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 272,227 shares — an estimated $5.17M sold.

Goldman Sachs first reported a position in OSIR in Q3 2013 and held it in 10 quarters. The position peaked at $5.17M in Q1 2019. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.

  • Goldman Sachs reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Goldman Sachs sold 272,227 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $5.17M.
  • Goldman Sachs first reported a position in Osiris Therapeutics, Inc. Common Stock in Q3 2013 and held it in 10 quarters.
  • Goldman Sachs's Osiris Therapeutics, Inc. Common Stock position peaked at $5.17M in Q1 2019.
  • 1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Goldman Sachs's 13F filing for Q2 2019, filed 14 Aug 2019.